Comprehensive studies in larger patient cohorts with detailed genomic analysis are essential to confirm the regulatory roles of NEAT1 and MALAT1, contributing to a comprehensive understanding of how APOBEC3 enzymes promote cancer evolution by causing genome and transcriptome heterogeneity. Here, NEAT1 is linked to cancer.